Tejnaksh Healthcare stock rallies over 4% post the launch of new product

Tejnaksh Healthcare Limited stocks rally in the market as the company has launched new product Andro-Sim.

As per the filing, the product Andro Sim is a silicon model used by doctors to educate patients and doctors as to examine a patient, treat patients with intracavernosal injections, Intraurethral instillations, Practice penile implant surgeries, Urethral dilatation etc. It is the first of its kind simulator ever made globally.

This Product is part of the simulator series launched and promoted by Tejnaksh Healthcare Itd.

This simulator will help the Urologist and patient to understand treatment of infertility and andrology more efficiently, the company said.

At around 10:27 AM, Tejnaksh Healthcare was trading at Rs115.90 per share higher by 4.09% as against previous closing of Rs111.35 per share on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com